Hong Kong
· Delayed Price · Currency is HKD XtalPi Holdings Company Description
XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan.
The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC.
Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research.
The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024.
XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China.
| Country | Cayman Islands |
| Founded | 2015 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 783 |
| CEO | Jian Ma |
Contact Details
Address: Second Phase of the International Shenzhen China | |
| Phone | 86 755 8190 1777 |
| Website | xtalpi.com |
Stock Details
| Ticker Symbol | 2228 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG1992K1067 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jian Ma Ph.D. | Chief Executive Officer and Executive Director |
| Dr. Shuhao Wen | Chairman |
| Man Hong Tam | Chief Financial Officer and Joint Company Secretary |
| Dr. Peiyu Zhang | Chief Scientific Officer |
| Dr. Lipeng Lai | Chief Innovation Officer and Executive Director |
| Dr. Yide Jiang | Chief Strategic Officer and Executive Director |
| Sau Ling Chan ACIS, ACS(PE), FCIS, P.E. | Joint Company Secretary |